Illness	Number of cases
Malignant neoplasm of bronchus and lung (C34.1)	13
Malignant neoplasm of bronchus and lung (C34.8)	9
Diarrhoea and gastroenteritis of presumed infectious origin (A09.9)	not specified
Malignant neoplasm of base of tongue (C01)	not specified
Malignant neoplasm of other and unspecified parts of tongue - Malignant neoplasm of overlapping sites of tongue (C02.8)	not specified
Malignant neoplasm of gum - Malignant neoplasm of lower gum (C03.1)	not specified
Malignant neoplasm of floor of mouth - Malignant neoplasm of overlapping sites of floor of mouth (C04.8)	not specified
Malignant neoplasm of other and unspecified parts of mouth - Malignant neoplasm of cheek mucosa (C06.0)	not specified
Malignant neoplasm of parotid gland (C07)	not specified
Malignant neoplasm of oropharynx - Malignant neoplasm of overlapping sites of oropharynx (C10.8)	not specified

Top 10 treatments

Treatment	Number
Making or modifying a device for radiotherapy (8-527.8)	1.522
Radiotherapy with high-energy beams for cancer - high voltage radiotherapy (8-522.90)	1.115
Radiotherapy with high-energy beams for cancer - high voltage radiotherapy (8-522.91)	494
Checking the settings before the start of a radiotherapy session (8-528.6)	131
Planning radiotherapy for irradiation through the skin or at a localised site (8-529.3)	129
Planning radiotherapy for irradiation through the skin or at a localised site (8-529.4)	117
Making or modifying a device for radiotherapy (8-527.1)	51
Making or modifying a device for radiotherapy (8-527.0)	48
Radiotherapy with high-energy beams for cancer - high voltage radiotherapy (8-522.d1)	36
Radiotherapy with high-energy beams for cancer - high voltage radiotherapy (8-522.31)	26

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 3300

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Chronische obstruktive Lungenerkrankung (COPD)

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
86	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
40	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
38	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities	Diverse Dozenturen/ Lehrbeauftragungen, siehe Auflistung unten
Lectureships / teaching posts at universities of applied sciences
Student training (clinical traineeship / internship year)	Lehrbeauftragte und apl. Professuren an der Universität Bochum
Project-related cooperation with colleges and universities	Prof. Dr. Szeimies: Leitlinienkonferenzen der DKG aktinische Keratosen und spinozelluläres Karzinom der Haut, EADO Basalzellkarzinom; Projekt Wilh.-Sander-Stiftung: Kombinationstherapie von kaltem atmosphärischem Plasma und Photodynamischer Therapie Verbesserung der Behandlung aktinischer Keratosen
Participation in multi-centre Phase I/II studies	Teilnahme an Leitlinienkonferenzen der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) Virushepatitis B und C sowie kolorektaler Karzinom
Participation in multi-centre phase III/IV studies	Prof. Dr. med. Hilker-Roggendorf: Teilnahme PRODAST-Studie (Orale Antikoagulation nach Schlaganfall), SWIFT-DIRECT Studie (Thrombektomie bei akutem Schlaganfall)
Initiation and management of uni-centric/multi-centric clinical/scientific studies	Prof. Dr. med. Rolf-Markus Szeimies: nationale und internationale Studienleitung bei 2 uni- und multizentrischen Studien zur Behandlung von hellem Hautkrebs und Vorstufen
Editors of scientific journals/textbooks	Klinische Neurophysiologie Neurolab Prof. Dr. med. Rolf-Markus Szeimies: Herausgeber „Der Hautarzt“; Editorial Board „Photodermatology, Photoimmunology & Photomedicine“
Doctoral supervision	PD Dr. Reiser gem. mit Prof. Dr. Szeimies: Retrospektive Analyse der Ursachen einer Zostererkrankung am stationären Krankengut der Klinik für Dermatologie und Allergologie im Zeitraum von 2009-2019

Training

No.	Training in other healing professions	Comment
HB01	Nurse and health care worker (m/f)	Theoretische und praktische Ausbildung
HB03	Physical therapist / physiotherapist (m/f)	Praktische Ausbildung
HB05	Medical technical radiology assistant (MTRA) (m/f)	Theoretische und praktische Ausbildung
HB07	Surgical technical assistant (m/f)	Ausbildung
HB17	Auxiliary nurse (m/f)	Theoretische und praktische Ausbildung
HB15	Anaesthesia technical assistant (m/f)	Ausbildung
HB19	Nursing professionals	Theoretische und praktische Ausbildung